EVALUATION OF THE ABСВ1 GENE POLYMORPHISMS EFFECTS ON THE АPIXABAN’S PHARMACOKINETIC PARAMETERS IN THE KAZAKH POPULATION
Introduction. Atrial fibrillation is a heart rhythm disorder. Apixaban is a direct-acting anticoagulant whose mechanism of action is to inhibit the activity of clotting factor Xa. The literature shows that polymorphisms of the ABCB1 gene are the most common genetic variants that contribute to the change in peak and trough levels of drugs with a proven clinical effect.
Purpose of the study. Study of the effect of ABCB1 gene polymorphisms on apixaban concentrations in patients with atrial fibrillation in the Kazakh population.
Methods. Genomic DNA was isolated from peripheral blood samples using a commercial Thermo Scientific GeneJET Whole Blood Genomic DNA Purification Mini Kit (Thermo Fisher Scientific) according to the manufacturer's instructions. DNA concentration was measured on a Nanodrop 1000 spectrophotometer. SNP genotyping was performed using TaqMan technology.
Results. In this study, no statistically significant differences were found in peak or minimum concentrations of apixaban in blood plasma with different genotypes of ABCB1 gene polymorphisms (rs4148738, rs1045642, rs2032582, rs1128503) in the Kazakh population.
Conclusions: Analysis of the influence of genetic factors on the activity of enzymes involved in the metabolism of the drug will help expand the possibilities of personalized medicine for individualizing treatment. It is necessary to conduct more extensive studies to study the effect of the carriage of ABCB1 polymorphisms on the metabolism of apixaban in various ethnic populations.
Number of Views: 285
Category of articles:
Original articles
Bibliography link
Abdrakhmanov A. Zholdybaeva Ye., Shaimerdinova A., Rib Ye., Abildinova C., Tuyakova G., Suleimen Zh., Bekbosynova M. Evaluation of the ABСВ1 gene polymorphisms effects on the Apixaban’s pharmacokinetic parameters in the Kazakh population // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 3, pp. 32-39. doi 10.34689/SH.2023.25.3.004Related publications:
A COMPARATIVE ANALYSIS OF 24-HOUR DIETARY RECALLS AND FOOD FREQUENCY QUESTIONNAIRES ADMINISTERED SIMULTANEOUSLY IN THE KAZAKHSTANI POPULATION
ANALYSIS OF PATIENT SATISFACTION WITH THE QUALITY OF ORGANIZATION OF TREATMENT IN FOREIGN CLINICS
CLINICAL AND LABORATORY PREDICTORS OF THE SEVERITY OF COVID-19 INFECTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
POST-MARKETING STUDY OF THE CLINICAL EFFICACY AND SAFETY OF GRIPMAX NOS IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS OF THE UPPER RESPIRATORY TRACT
EXPERIENCE IN IMPROVING SURGICAL TREATMENT WHEN IMPOSING A STOMA IN CHILDREN WITH HIRSPRUNG'S DISEASE